Over the past few decades, tremendous advances in the prevention, diagnosis, and
treatment of cancer have taken place. However for head and neck cancers, including oral …

Background Evidence suggests that inflammation contributes to tumor development, from
onset to progression and metastasis. Platelet-to-lymphocyte ratio (PLR) is a composite …

Inflammatory biomarkers may be associated with disease severity and increased mortality in
COVID-19 patients but have not been studied in North American populations. We sought to …

Background The prognostic role of the C‐reactive protein (CRP) in head and neck
squamous cell carcinoma (HNSCC) has not been well investigated. This meta‐analysis …

Background: Head and neck squamous cell carcinoma (HNSCC) is a highly prevalent and
malignant tumor that is difficult to effectively prognosticate outcomes. Recent reports have …

TGF-β1 and TGF-βR1 play important roles in immune and inflammatory responses. Genetic
variants of TGF-β1 rs1800470 and TGF-βR1 rs334348 have emerged as potentially …

Immunotherapy has become one of the most promising approaches in tumor therapy, and
there are numerous associated clinical trials in China. As an immunosuppressive tumor …

Simple Summary Head and neck cancer (HNC) treatment poses several challenges in
clinical practice, and treatment side effects can be debilitating due to the close proximity of …

ABSTRACT Extra-cellular galectins 1, 3 and 9 (gal-1,− 3 and− 9) are known to act as soluble
immunosuppressive agents in various malignancies. Previous publications have suggested …

Objective This study evaluated the association of pretreatment serum C-reactive protein
(CRP) level with prognosis in patients with head and neck squamous cell carcinoma …